Experimental parkinsonism induced by tetanus toxin injected into basal ganglia
Patrik MeglićiD, Petra ŠoštarićiD, Davor ViragiD, Ana KnezovićiD, Nikola HabekiD, Ornella RossettoiD, Ivica MatakiD
Abstract
Background and ObjectivesLocal inhibitory circuits and long-range inhibitory projections within the interconnected basal ganglia nuclei are critical for control of voluntary movement and pathophysiology of different extrapyramidal movement disorders. Herein, we examined the major motor effects of tetanus neurotoxin (TeNT), a presynaptic neurotoxin that selectively targets the GABA-ergic synaptic transmission, when injected into individual basal ganglia nuclei. MethodsThe rats were injected with low-dose TeNT (0.4-0.8 ng) unilaterally into globus pallidus internus (GPi), substantia nigra (SN), or caudate putamen (CPu). The effects of TeNT-induced disinhibition were characterized by repeated assessments of motor coordination, gait, and rotational behavior, followed by measurement of regional protein content of major neuronal monoaminergic, GABA-ergic and glutamatergic population markers. ResultsIn the beamwalk test, the CPu injection of TeNT induced contralateral plantar misplacement. TeNT injections into GPi and CPu were associated with decreased stride length and increased duration of step cycle and induced a slight ipsiversive circling during open field observation, and more intensive rotational behavior during swimming, differentially affected by D-amphetamine. Unlike rotational behavior, the gait and motor control deficits during beamwalk recovered promptly by day 14 post TeNT, which, along with the lack of reduced neuronal marker protein contents, suggested the reversibility and lack of neuronal degeneration. Conclusion and ImplicationsTetanus toxin injected into basal ganglia evokes transient hypokinetic motor dysfunctions consistent with experimental parkinsonism, with differential occurrence of individual motor symptoms depending on the region targeted. These results suggest that TeNT might be a useful non-neurodegenerative pharmacological agent for investigating the motor control abnormalities involving GABA-ergic basal ganglia circuits.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 1.07
- Field percentile
- top 25%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Inhibitory basal ganglia nuclei differentially innervate pedunculopontine nucleus subpopulations and evoke opposite motor and valence behaviors.
Michel Fallah, Kenea C Udobi, … Rebekah C. Evans·eLifePeer-reviewed·Aug 11, 2025
- tVTA controls dual dopaminergic inputs to the external Globus Pallidus
Margaux Lebouc, Giulia R. Fois, … François E. Georges·bioRxiv·Apr 21, 2026
- Unilateral damage to the entopeduncular nucleus causes forelimb motor dysfunction in rats
Ryo Sakai, Kazuki Kuroda, … Yugo Fukazawa·bioRxiv·May 30, 2025
- Prospective control of movement in the basal ganglia
David N. Lee, Apostolos P. Georgopoulos, Gert‐Jan Pepping·bioRxiv·Jan 30, 2018
- Function of basal ganglia in tauG-guiding action
David N. Lee, Apostolos P. Georgopoulos, Gert‐Jan Pepping·bioRxiv·May 27, 2017
- Subthalamic nucleus stabilizes movements by reducing neural spike variability in monkey basal ganglia: chemogenetic study
Taku Hasegawa, Satomi Chiken, … Atsushi Nambu·bioRxiv·Apr 13, 2021